🇺🇸 FDA
Patent

US 9062093

Peptide compositions and methods for treating patients

granted A61KA61K38/06A61P

Quick answer

US patent 9062093 (Peptide compositions and methods for treating patients) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K38/06, A61P, A61P3/00, A61P3/04